OliX Pharmaceuticals, Inc (KOSDAQ:226950)

OliX Pharmaceuticals Revenue

OliX Pharmaceuticals had revenue of 6.25B KRW in the quarter ending June 30, 2025, with 35.90% growth. This brings the company's revenue in the last twelve months to 7.54B, down -57.89% year-over-year. In the year 2024, OliX Pharmaceuticals had annual revenue of 5.68B, down -66.73%.

• Revenue (ttm): 7.54B
• Revenue Growth: -57.89%
• P/S Ratio: 267.05
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2,012.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.68B	-11.39B	-66.73%
Dec 31, 2023	17.06B	7.74B	83.09%
Dec 31, 2022	9.32B	5.65B	153.66%
Dec 31, 2021	3.67B	1.20B	48.50%
Dec 31, 2020	2.47B	1.34B	118.90%